Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial.

Managing lingering pain after cancer treatment is tricky, especially with growing caution around opioid painkillers. This trial asked whether two forms of acupuncture, electroacupuncture and auricular (ear) acupuncture, could ease chronic musculoskeletal pain in cancer survivors better than usual care alone. Over 350 adults with pain lasting at least three months were randomly assigned to ten weekly sessions of one of the two acupuncture approaches or to usual care, with usual care participants later offered acupuncture too. Both acupuncture types reduced pain more than usual care over twelve weeks, with the difference being statistically significant for each comparison.

However, ear acupuncture did not meet the study's criteria for being considered equally effective as electroacupuncture, and more people receiving ear acupuncture stopped treatment because of side effects. The trial does not tell us whether one method truly outperformed the other, only that each beat usual care, and the findings apply specifically to survivors without current disease evaluated over a defined follow-up period.

If you're a cancer survivor living with ongoing muscle or joint pain, you may wonder whether acupuncture could help, particularly given concerns about relying on opioid medications for pain control. This study looked at two types of acupuncture, one using small electrical pulses through needles and one focused on the ear, comparing each against usual care in over 350 survivors with pain lasting three months or more. Both acupuncture approaches led to greater reductions in pain than usual care did after twelve weeks.

That's a meaningful signal, though the study can't confirm that ear acupuncture works just as well as electroacupuncture, since it fell short of the statistical bar for that comparison. People who tried ear acupuncture were also more likely to stop early due to side effects, which were described as mild. This was one sizeable trial, not years of accumulated evidence, and it followed people for a defined period rather than long term.

It gives useful information but leaves open questions about which approach might suit different people better.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomized trial (n=360, 2:2:1 allocation to electroacupuncture, auricular acupuncture, or usual care) addressed chronic musculoskeletal pain in cancer survivors without current disease, using a gatekeeping procedure with blinded statisticians. Both electroacupuncture (mean reduction 1.9 points, 97.5% CI 1.4-2.4, on the Brief Pain Inventory) and auricular acupuncture (1.6 points, 97.5% CI 1.0-2.1) produced statistically significant reductions in pain severity relative to usual care at week 12, from a baseline mean of 5.2 points. The prespecified noninferiority test of auricular versus electroacupuncture was not met, meaning the trial cannot support treating the two as equivalent, and the abstract does not report a direct head-to-head superiority comparison beyond this.

Discontinuation due to adverse events was notably higher in the auricular group (10.5% vs 0.7%, p<.001), though events were characterized as mild. Strengths include adequate completion rate (94.4%) and blinded analysis; limitations include the open-label nature of acupuncture delivery, a defined 12-week primary endpoint, and uncertainty about durability or generalizability beyond this survivor population with confirmed absence of active disease.